Stockreport

Annovis to Host Patients’ Live Forum on February 27, 2025

Annovis Bio, Inc.  (ANVS) 
PDF MALVERN, Pa., Feb. 19, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS)  ("Annovis" or the "Company"), a clinical-stage drug platform company developi [Read more]